Advertisement
Advertisement
DXCM
DexCom, Inc.
68.10
USDSponsored
-2.59
-3.67%
Mar 06, 15:59 UTC -5
Closed
After-Market
68.31
+0.22
+0.32%
DXCM Earnings Reports
Positive Surprise Ratio
DXCM beat 31 of 41 last estimates.
76%
Next Report
Date of Next Report
Apr 29, 2026
Estimate for Q1 26 (Revenue/ EPS)
$1.20B
/$0.47
Implied change from Q4 25 (Revenue/ EPS)
-4.84%
/+4.44%
Implied change from Q1 25 (Revenue/ EPS)
+15.70%
/+46.87%
DexCom, Inc. earnings per share and revenue
On Feb 12, 2026, DXCM reported earnings of 0.45 USD per share (EPS) for Q4 25, missing the estimate of 0.66 USD, resulting in a -32.13% surprise. Revenue reached 1.26 billion, compared to an expected 1.27 billion, with a -0.87% difference. The market reacted with a -1.03% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 23 analysts forecast an EPS of 0.47 USD, with revenue projected to reach 1.20 billion USD, implying an increase of 4.44% EPS, and decrease of -4.84% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Masimo Corporation
Report Date
Feb 26, 2026 For Q4 25
Estimate
$1.50
Actual
-Surprise
-
Teleflex Incorporated
Report Date
Feb 26, 2026 For Q4 25
Estimate
$3.77
Actual
$1.93
Surprise
-48.83%
Opko Health Inc.
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+42.28%
Integra LifeSciences Holdings
Report Date
Feb 26, 2026 For Q4 25
Estimate
$0.81
Actual
$0.83
Surprise
+1.68%
Neuropace, Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.15
Actual
-$0.08
Surprise
+48.22%
OrthoPediatrics Corp. Common Stock
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.34
Actual
-$0.43
Surprise
-25.36%
Delcath Systems Inc
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.05
Surprise
+20.51%
Sight Sciences, Inc. Common Stock
Report Date
Mar 04, 2026 For Q4 25
Estimate
-$0.14
Actual
-$0.08
Surprise
+43.66%
908 Devices Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.05
Surprise
+29.97%
Anteris Technologies Global Corp. Common Stock
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.59
Actual
-$0.74
Surprise
-24.18%
FAQ
What were DexCom, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, DexCom, Inc. reported EPS of $0.45, missing estimates by -32.13%, and revenue of $1.26B, -0.87% below expectations.
How did the market react to DexCom, Inc.'s Q4 2025 earnings?
The stock price moved down -1.03%, changed from $70.98 before the earnings release to $70.25 the day after.
When is DexCom, Inc. expected to report next?
The next earning report is scheduled for Apr 29, 2026.
What are the forecasts for DexCom, Inc.'s next earnings report?
Based on 23
analysts, DexCom, Inc. is expected to report EPS of $0.47 and revenue of $1.20B for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement